VF
RLAY icon

Virtu Financial’s Relay Therapeutics RLAY Stock Holding History

Virtu Financial’s Portfolio RLAY Stock Details RLAY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-15,046
Closed -$62K – 1936
2024
Q4 		$62K Sell
15,046
-31,964
-68% -$174K ﹤0.01% 1120
2024
Q3 		$333K Buy
+47,010
New +$351K 0.02% 588
2024
Q2 		– Sell
-10,461
Closed -$87K – 1802
2024
Q1 		$87K Buy
+10,461
New +$102K 0.01% 943
2021
Q4 		– Sell
-7,512
Closed -$237K – 2106
2021
Q3 		$237K Buy
+7,512
New +$253K 0.02% 830
2021
Q2 		– Sell
-6,929
Closed -$240K – 1989
2021
Q1 		$240K Sell
6,929
-2,369
-25% -$103K 0.02% 955
2020
Q4 		$386K Buy
+9,298
New +$420K 0.04% 532

Other funds holding RLAY

SIAU
SB Investment Advisers (UK) London, United Kingdom $7.73B AUM 2.35% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
CC
Casdin Capital New York $1.32B AUM 76.62% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $935B AUM

Virtu Financial's RLAY Position: Q1 2025 in Review

Virtu Financial sold out of Relay Therapeutics (RLAY) in Q1 2025, closing a stake of 15,046 shares — an estimated $62K sold.

Virtu Financial first reported a position in RLAY in Q4 2020 and held it in 6 quarters. The position peaked at $386K in Q4 2020. 207 funds tracked by Wall St. Rank hold RLAY as of Q1 2025.

  • Virtu Financial reported no remaining Relay Therapeutics position as of Q1 2025 after selling out during the quarter.
  • Virtu Financial sold 15,046 Relay Therapeutics shares in Q1 2025, an estimated $62K.
  • Virtu Financial first reported a position in Relay Therapeutics in Q4 2020 and held it in 6 quarters.
  • Virtu Financial's Relay Therapeutics position peaked at $386K in Q4 2020.
  • 207 funds tracked by Wall St. Rank held Relay Therapeutics as of Q1 2025.

Based on Virtu Financial's 13F filing for Q1 2025, filed 12 May 2025.